Anika Therapeutics, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $198.00K, a 24.14% decline year-over-year.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $261.00K, a 36.50% decline year-over-year.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $411.00K, a 9.87% decline year-over-year.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $456.00K.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $501.00K, a 29.24% decline from fiscal 2024.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $708.00K, a 12.05% decline from fiscal 2023.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $805.00K, a 21.05% increase from fiscal 2022.
- Anika Therapeutics, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $665.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $198.00K 10-Q · filed 2026-07-29 | |
| 2025-12-31 | $501.00K 10-K · filed 2026-03-03 | |
| 2025-06-30 | $261.00K 10-Q · filed 2026-07-29 | |
| 2024-12-31 | $708.00K 10-K · filed 2026-03-03 | |
| 2024-06-30 | $411.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $805.00K 10-K · filed 2026-03-03 | |
| 2023-06-30 | $456.00K 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $665.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |